Keywords: ناب-پکلیتاکسل; Advanced pancreatic carcinoma; Cholestasis; Hyperbilirubinaemia; Chemotherapy; Nab-paclitaxel; Gemcitabine;
مقالات ISI ناب-پکلیتاکسل (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: ناب-پکلیتاکسل; adjuvant; capecitabine; FOLFIRINOX; gemcitabine; liposomal irinotecan metastatic; nab-paclitaxel; pancreatic cancer;
Keywords: ناب-پکلیتاکسل; Elderly; nab-Paclitaxel; Retrospective; Squamous; Treatment duration;
Keywords: ناب-پکلیتاکسل; Pancreatic cancer; FOLFIRINOX; Gemcitabine; Nab-paclitaxel; Targeted agents; Novel strategies;
Keywords: ناب-پکلیتاکسل; Adenocarcinoma; Capecitabine; Erlotinib; Gemcitabine; Nab-paclitaxel; Oxaliplatin; Pancreas; Pneumonitis;
Keywords: ناب-پکلیتاکسل; Nab-paclitaxel; Non-small cell lung cancer (NSCLC); Carboplatin; Neuropathy; Squamous cell histology; Elderly;
Keywords: ناب-پکلیتاکسل; Nab-paclitaxel; Breast cancer; Metastatic; Tailored treatment; Nanoparticle;
Keywords: ناب-پکلیتاکسل; Taxane; paclitaxel; docetaxel; hypersensitivity; skin test; allergy; risk stratification; desensitization; challenge; BWH; Brigham and Women's Hospital; DFCI; Dana-Farber Cancer Institute; HSR; Hypersensitivity reaction; nab-paclitaxel; Nanoparticle album
Keywords: ناب-پکلیتاکسل; Pancreatic cancer; Metastatic disease; Gemcitabine; Nab-paclitaxel; FOLFIRINOX; Targeted agents; Immune therapy;
Keywords: ناب-پکلیتاکسل; Pancreatic cancer; Metastatic disease; Gemcitabine; FOLFIRINOX; Nab-paclitaxel; Targeted therapy;
Keywords: ناب-پکلیتاکسل; Pancreatic cancer; Pancreatic adenocarcinoma; Stroma; Gemcitabine; Nab-paclitaxel; FOLFIRINOX; Nanoliposomal irinotecan
Keywords: ناب-پکلیتاکسل; Breast cancer; HER-2-negative; Resistance; Biologic targeted agent; Combination therapy; ABC; advanced breast cancer; AE; adverse event; AI; aromatase inhibitor; AKT; protein kinase; BC; breast cancer; CDK; cyclin-dependent kinase; CT; chemotherapy; CTLA;
Keywords: ناب-پکلیتاکسل; CA 19-9; Granulocyte-colony stimulating factor; Nab-paclitaxel; Response; Toxicity
Keywords: ناب-پکلیتاکسل; nab-Paclitaxel; Solvent-based paclitaxel; Functional Assessment of Cancer Therapy-Taxane; Non–small-cell lung cancer; Peripheral neuropathy
Keywords: ناب-پکلیتاکسل; Extracellular matrix; Gemcitabine; Nab-paclitaxel; Pancreatic cancer; Sonic hedgehog; SPARC; Stellate cells; Stem cells; Stroma;
Keywords: ناب-پکلیتاکسل; Cytotoxic chemotherapy; Docetaxel; Metastatic breast cancer; Nab-paclitaxel; Solvent-based paclitaxel; Taxanes
Nab-paclitaxel plus carboplatin as an effective and safe chemotherapy regimen for pulmonary carcinosarcoma with interstitial lung disease: A case report
Keywords: ناب-پکلیتاکسل; Carcinosarcoma; Chemotherapy; Nab-paclitaxel; Carboplatin; Interstitial lung disease;
A phase II study of nab-paclitaxel in combination with ramucirumab in patients with previously treated advanced gastric cancer
Keywords: ناب-پکلیتاکسل; Advanced gastric cancer; Nab-paclitaxel; Paclitaxel; Ramucirumab; Overall response rate; Second-line chemotherapy;
Induction chemotherapy with carboplatin, nab-paclitaxel and cetuximab for at least N2b nodal status or surgically unresectable squamous cell carcinoma of the head and neck
Keywords: ناب-پکلیتاکسل; Head and neck cancer; Locally advanced; Induction; Neo-adjuvant; Nab-paclitaxel;
Phase I results of a phase I/II study of weekly nab-paclitaxel in paediatric patients with recurrent/refractory solid tumours: A collaboration with innovative therapies for children with cancer
Keywords: ناب-پکلیتاکسل; nab-paclitaxel; Paediatric; Neuroblastoma; Rhabdomyosarcoma; Ewing sarcoma; Solid tumour;
Quality-Adjusted Survival With nab-Paclitaxel Versus Standard Paclitaxel in Metastatic Breast Cancer: A Q-TWiST Analysis
Keywords: ناب-پکلیتاکسل; Chemotherapy; Metastatic breast cancer; nab-Paclitaxel; Taxanes; Quality-adjusted time without symptoms of disease progression or toxicity of treatment;
Quality-adjusted Outcomes Stratified by Response in Patients With Advanced Non-Small-cell Lung Cancer Receiving First-line nab-Paclitaxel/Carboplatin or Paclitaxel/Carboplatin
Keywords: ناب-پکلیتاکسل; Nab-paclitaxel; NSCLC; Responders; Q-TWiST; Quality of life;
Feasibility Study of Weekly Nanoparticle Albumin-Bound Paclitaxel (150 mg/m2) Followed by Fluorouracil, Epirubicin, and Cyclophosphamide Therapy as Neoadjuvant Chemotherapy for HER2-Negative Breast Cancer
Keywords: ناب-پکلیتاکسل; Breast cancer; Nab-paclitaxel; Neoadjuvant chemotherapy; Peripheral neuropathy; Phase II;
Phase I/II study of carboplatin plus nab-paclitaxel and concurrent radiotherapy for patients with locally advanced non-small cell lung cancer
Keywords: ناب-پکلیتاکسل; Nab-paclitaxel; Carboplatin; Chemoradiation; Radiotherapy; Locally advanced non-small cell lung cancer (NSCLC);
Concomitant Delivery of Paclitaxel and NuBCP-9 peptide for synergistic enhancement of cancer therapy
Keywords: ناب-پکلیتاکسل; Paclitaxel; nab-paclitaxel; polymeric nanoparticles; NuBCP-9; BCL-2; NP; nanoparticle; P-gp; Poly-glycoproteins; PTX; Paclitaxel; nab-paclitaxel; albumin based paclitaxel loaded nanoparticles; NuBCP-9; Nur77 derived BCL-2 converting 9 mer peptide; caspase
Phase II trial of albumin-bound paclitaxel and granulocyte macrophage colony-stimulating factor as an immune modulator in recurrent platinum resistant ovarian cancer
Keywords: ناب-پکلیتاکسل; Ovarian cancer; GM-CSF; Nab-paclitaxel; Myeloid derived suppressor cells; Chemo-immunotherapy;
Original ArticleGemcitabine enhances the transport of nanovector-albumin-bound paclitaxel in gemcitabine-resistant pancreatic ductal adenocarcinoma
Keywords: ناب-پکلیتاکسل; Pancreatic cancer; Gemcitabine; Drug resistance; nAb-paclitaxel; Multistage nanovectors; Transport;
Efficacy and treatment-related adverse events of gemcitabine plus nab-paclitaxel for treatment of metastatic pancreatic cancer “in a Korean” population: A single-center cohort study
Keywords: ناب-پکلیتاکسل; pancreatic cancer; chemotherapy; gemcitabine; nab-paclitaxel; prognosis;
Phase II trial of weekly nab-paclitaxel for previously treated advanced non-small cell lung cancer: Kumamoto thoracic oncology study group (KTOSG) trial 1301
Keywords: ناب-پکلیتاکسل; Non-small cell lung cancer; Nab-paclitaxel; Objective response rate; Overall survival; Phase II trial;
Development of peripheral neuropathy and its association with survival during treatment with nab-paclitaxel plus gemcitabine for patients with metastatic adenocarcinoma of the pancreas: A subset analysis from a randomised phase III trial (MPACT)
Keywords: ناب-پکلیتاکسل; Gemcitabine; nab-Paclitaxel; Peripheral neuropathy; Pancreatic cancer;
nab-Paclitaxel, cisplatin, and 5-fluorouracil followed by concurrent cisplatin and radiation for head and neck squamous cell carcinoma
Keywords: ناب-پکلیتاکسل; Head and neck cancer; nab-Paclitaxel; Cisplatin; 5-Fluorouracil; Induction; Chemotherapy
New treatment strategy with nuclear factor-κB inhibitor for pancreatic cancer
Keywords: ناب-پکلیتاکسل; Nafamostat mesilate; Pancreatic cancer; Gemcitabine; Nab-paclitaxel; Orthotopic mouse model; NF-κB
Taxanes in the treatment of breast cancer: Have we better defined their role in older patients? A position paper from a SIOG Task Force
Keywords: ناب-پکلیتاکسل; Breast cancer; Elderly; Docetaxel; Paclitaxel; Nab-paclitaxel; Taxanes
Nab-paclitaxel for the treatment of triple-negative breast cancer: Rationale, clinical data and future perspectives
Keywords: ناب-پکلیتاکسل; Nab-paclitaxel; Triple-negative breast cancer; Chemotherapy
High Pathologic Complete Response in Her2-Positive, Early-Stage Breast Cancer to a Novel Nonanthracycline Neoadjuvant Chemotherapy
Keywords: ناب-پکلیتاکسل; Breast cancer; Nab-paclitaxel; Neoadjuvant chemotherapy; Pathologic complete response; Trastuzumab;
Le nab-paclitaxel
Keywords: ناب-پکلیتاکسل; Nab-paclitaxel; Adénocarcinome pancréas; Cancer du sein; Paclitaxel; Protéine SPARC; Nab-paclitaxel; Pancreatic adenocarcinoma; Breast cancer; Paclitaxel; SPARC protein;
Stromal Caveolin-1 Is Associated With Response and Survival in a Phase II Trial of nab-Paclitaxel With Carboplatin for Advanced NSCLC Patients
Keywords: ناب-پکلیتاکسل; Caveolin-1; Clinical Trial; nab-paclitaxel; Sensory neuropathy; SPARC;
nab-Paclitaxel for the Treatment of Aggressive Metastatic Breast Cancer
Keywords: ناب-پکلیتاکسل; Aggressive; Metastatic breast cancer; nab-Paclitaxel; Poor prognosis; Triple-negative breast cancer
Phase 1 study of nab-paclitaxel, cisplatin and 5-fluorouracil as induction chemotherapy followed by concurrent chemoradiotherapy in locoregionally advanced squamous cell carcinoma of the oropharynx
Keywords: ناب-پکلیتاکسل; Head & neck cancer; Squamous cell carcinoma; Induction chemotherapy; Sequential therapy; Nab-paclitaxel
nab-Paclitaxel in combination with biologically targeted agents for early and metastatic breast cancer
Keywords: ناب-پکلیتاکسل; nab-Paclitaxel; Paclitaxel; Bevacizumab; Trastuzumab; Metastatic breast cancer; Neoadjuvant; Adjuvant
Nab-paclitaxel: A flattering facelift
Keywords: ناب-پکلیتاکسل; Nab-paclitaxel; Nanotechnology; SPARC; Nanomedicine; Breast cancer; Pancreatic cancer
Treatment innovations for metastatic breast cancer: Nanoparticle albumin-bound (NAB) technology targeted to tumors
Keywords: ناب-پکلیتاکسل; Metastatic breast cancer; Nab-paclitaxel; Taxane; SPARC; Chemotherapy;
Original studyNab-Paclitaxel/Bevacizumab/Carboplatin Chemotherapy in First-Line Triple Negative Metastatic Breast Cancer
Keywords: ناب-پکلیتاکسل; Bevacizumab; Carboplatin; Metastatic breast cancer; Nab-paclitaxel; Triple negative breast cancer;
nab-Paclitaxel mechanisms of action and delivery
Keywords: ناب-پکلیتاکسل; nab-Paclitaxel; Mechanism of action; Mechanism of delivery; Taxane; Cancer;
Efficacy and safety of weekly nab-paclitaxel plus carboplatin in patients with advanced non-small cell lung cancer
Keywords: ناب-پکلیتاکسل; ABI-007; Abraxane; Carboplatin; Japanese; Nab-paclitaxel; Non-small cell lung cancer (NSCLC); Squamous cell carcinoma (SCC); Weekly
Cáncer de páncreas exocrino
Keywords: ناب-پکلیتاکسل; Cáncer de páncreas exocrino; Biología molecular; Gemcitabina; Nab-paclitaxelExocrine pancreatic cancer; Molecular biology; Gemcitabine; Nab-paclitaxel
Challenges, expectations and limits for nanoparticles-based therapeutics in cancer: A focus on nano-albumin-bound drugs
Keywords: ناب-پکلیتاکسل; Nanoparticles; Pharmacokinetics; Delivery systems; Oncology; Nab-paclitaxel
Phase II trial of nab-paclitaxel in the treatment of recurrent or persistent advanced cervix cancer: A gynecologic oncology group study
Keywords: ناب-پکلیتاکسل; Nab-paclitaxel; GOG; Cervix cancer; Drug resistant cervix cancer;
Emerging therapies for urothelial cancer
Keywords: ناب-پکلیتاکسل; Anti-EGFR; Bladder cancer; Emerging treatments; Eribulin; mTOR inhibition; Nab-paclitaxel; PARP; Sorafenib; Sunitinib; Volasertib
A phase II evaluation of nanoparticle, albumin-bound (nab) paclitaxel in the treatment of recurrent or persistent platinum-resistant ovarian, fallopian tube, or primary peritoneal cancer: A Gynecologic Oncology Group Study
Keywords: ناب-پکلیتاکسل; Ovarian cancer; Fallopian tube cancer; Primary peritoneal cancer; Platinum-resistant; Taxane-resistant; Nab-paclitaxel